Thursday, 14 April 2016

Pharma companies

Sun Pharmaceutical Industries Limited is counted among the best Pharma companies of Bangalore and listed in the stock market as (NSE: SUNPHARMA, BSE: 524715). It is an Indian multinational pharmaceutical company that has headquartered in Mumbai, Maharashtra and has been known for manufacturing quality products at affordable price. Company manufactures and sells pharmaceutical products and has huge market share in India and the United States. Company primarily manufactures drugs for cardiology, psychiatry, neurology, gastroenterology and diabetology.

Sun Pharmaceuticals was started by Mr. Dilip Shanghvi in the year 1983 in Vapi and has been manufacturing various products to treat psychiatry ailments. Cardiology products Company had introduced in 1987 and after 20 years has become the largest chronic prescription company. In the year 2014 to expend business company has acquired Ranbaxy and has made the Sun Pharma a largest Indian pharma company in the US and India.
More than 72% of the company comes from overseas market and US is the single largest market of the company and contribute 50% turnover of the company. Company has manufacturing units at 26 locations that includes production plants in US, Canada, Brazil, Mexico and Israel. Overall company has excellent team of capable employees that has deep domain knowledge of their respective field.
Company has very strong management team that includes
·         Israel Makov: Chairman
·         Dilip Shanghvi: Managing Director
·         Sudhir V. Valia: Executive Director
·         Sailesh T. Desai: Executive Director
·         Hasmukh S. Shah: Non Executive Independent Director
·         Keki M Mistry: Non Executive Independent Director
·         Ashwin Dani: Non Executive Independent Director
·         S. Mohanchand Dadha: Non Executive Independent Director
·         Rekha Sethi: Non Executive Independent Director
·         Vijay Patel: Non Executive Independent Director

Below mention is the essential information about the company :
Type : Public | Traded as BSE: 524715, NSE: SUNPHARMA | Industry : Pharmaceuticals | Founded             2001  | Headquarters : Mumbai, Maharashtra, India | Key people : dilip shangavi (Chairman), Dilip Shanghvi (Managing Director) | Products : Pharmaceuticals, generic drugs | Revenue               Increase ₹133627 crore (US$20 billion) (2015) | Operating income : Increase ₹36500 crore (US$5.4 billion) (2015) | Net income : Increase  : ₹55000 crore (US$8.1 billion) (2015) | Total assets : Increase ₹155000 crore (US$23 billion) (2015) | Number of employees : 32,700 (March 2015) 

Information about Pharma Companies in Mumbai - http://companiesinindia.net/pharma/mumbai.html

1 comment: